Hang Chi Holdings Limited (8405.HK)

HKD 0.69

(1.47%)

EBITDA Summary of Hang Chi Holdings Limited

Hang Chi Holdings Limited's latest annual EBITDA in 2023 was 81.58 Million HKD , down -16.07% from previous year.
Hang Chi Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 10.75 Million HKD , down 0.0% from previous quarter.
Hang Chi Holdings Limited reported an annual EBITDA of 91.11 Million HKD in 2022, down -12.67% from previous year.
Hang Chi Holdings Limited reported an annual EBITDA of 97.87 Million HKD in 2021, down -3.15% from previous year.
Hang Chi Holdings Limited reported a quarterly EBITDA of 10.75 Million HKD for 2024 Q1, down -76.4% from previous quarter.
Hang Chi Holdings Limited reported a quarterly EBITDA of N/A for 2023 FY, down -16.07% from previous quarter.

Annual EBITDA Chart of Hang Chi Holdings Limited (2023 - 2015)

Historical Annual EBITDA of Hang Chi Holdings Limited (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	81.58 Million HKD	-16.07%
2022	91.11 Million HKD	-12.67%
2021	97.87 Million HKD	-3.15%
2020	100.73 Million HKD	56.59%
2019	64.53 Million HKD	94.41%
2018	35.6 Million HKD	180.46%
2017	23.69 Million HKD	0.67%
2016	13.1 Million HKD	-23.02%
2015	41.01 Million HKD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	10.75 Million HKD	0.0%
2024 Q1	10.75 Million HKD	-76.4%
2023 FY	- HKD	-16.07%
2023 Q1	15.59 Million HKD	-44.27%
2023 Q2	20.42 Million HKD	30.96%
2023 Q3	20.02 Million HKD	-1.92%
2023 Q4	41.26 Million HKD	106.0%
2022 Q2	22.04 Million HKD	14.85%
2022 FY	- HKD	-12.67%
2022 Q4	27.97 Million HKD	27.77%
2022 Q3	21.89 Million HKD	-0.67%
2022 Q1	19.19 Million HKD	-20.35%
2021 FY	- HKD	-3.15%
2021 Q1	22.9 Million HKD	-16.04%
2021 Q4	24.09 Million HKD	-8.45%
2021 Q3	26.32 Million HKD	7.21%
2021 Q2	24.55 Million HKD	7.21%
2020 Q4	27.27 Million HKD	-8.73%
2020 FY	- HKD	56.59%
2020 Q1	20.2 Million HKD	0.36%
2020 Q2	23.36 Million HKD	15.67%
2020 Q3	29.88 Million HKD	27.9%
2019 Q3	21.37 Million HKD	70.86%
2019 FY	- HKD	94.41%
2019 Q4	20.12 Million HKD	-5.83%
2019 Q2	12.51 Million HKD	18.95%
2019 Q1	10.51 Million HKD	114.35%
2018 Q3	11.26 Million HKD	15.35%
2018 Q1	7.25 Million HKD	13.55%
2018 Q2	9.76 Million HKD	34.62%
2018 FY	- HKD	180.46%
2018 Q4	4.9 Million HKD	-56.44%
2017 Q3	-2.31 Million HKD	-156.88%
2017 FY	- HKD	0.67%
2017 Q1	3.68 Million HKD	15.9%
2017 Q4	6.38 Million HKD	375.51%
2017 Q2	4.07 Million HKD	10.52%
2016 Q3	4.35 Million HKD	12.51%
2016 FY	- HKD	-23.02%
2016 Q4	3.18 Million HKD	-26.93%
2016 Q2	3.87 Million HKD	0.0%
2016 Q1	3.87 Million HKD	19.71%
2015 Q4	3.23 Million HKD	0.0%
2015 FY	- HKD	0.0%

Peer EBITDA Comparison of Hang Chi Holdings Limited

Name	EBITDA	EBITDA Difference
Aidigong Maternal & Child Health Limited	68.84 Million HKD	-18.503%
UMP Healthcare Holdings Limited	161.98 Million HKD	49.632%
Human Health Holdings Limited	104.06 Million HKD	21.599%
EuroEyes International Eye Clinic Limited	292.1 Million HKD	72.069%
Kato (Hong Kong) Holdings Limited	133.61 Million HKD	38.937%
Bamboos Health Care Holdings Limited	52.75 Million HKD	-54.644%
Beijing Health (Holdings) Limited	-44.19 Million HKD	284.624%
C-MER Eye Care Holdings Limited	359.88 Million HKD	77.33%
Town Health International Medical Group Limited	53.5 Million HKD	-52.496%
Medicskin Holdings Limited	6.77 Million HKD	-1104.058%